Pharmacalogical Administration of Anti Mullerian Hormone (Amh) Prevents Loss of Ovarian Reserve and Protects Fertility in Chemotherapy Treated Mice

Hadassa Roness 1 Itai Spector 1 Sanaz Dereh-Haim 1 Hila Raanani 1,2 Dror Meirow 1,2
1Fertility Preservation Center, Sheba Medical Center
2Sackler School of Medicine, Tel Aviv University

Loss of AMH as a result of the death of growing follicles has been implicated in chemotherapy-induced follicle loss and presents a potential target for pharmacological fertility preservation.

Aim: To determine whether replacement of negative regulator, AMH, at the time of treatment can prevent chemotherapy-induced follicle activation and loss, and to test the in vivo functionality of a partial recombinant (r)AMH molecule.

Methods:

  • Biotin-labeled C-terminal fragment rAMH was injected IP into normal (n=12) and low-reserve female mice (n=20) to assess delivery method. Ovaries were removed for protein analysis and immuno-histochemistry.
  • Mature female mice (n=30) were treated with 150mg/kg Cy/PBS, +/- 5µg rAMH. Ovaries were processed histologically for differential follicle counts.

Results: In both normal and low-reserve mice a single IP injection of rAMH achieved a significant presence in the ovaries.

Mice treated with rAMH during chemotherapy retained a significantly higher number of primordial follicles both in the short (7 days) and long term (21 days) after treatment (p< 0.02 compared to mice treated with Cy alone), and had fewer growing follicles in the short term (p

Conclusion: This proof of principle study demonstrates that suppression of follicle activation using AMH prevents chemotherapy-induced follicle reserve loss, and further that the partial molecule rAMH has physiological activity. These results confirm both that follicle activation is a significant cause of chemotherapy induced follicle loss, and suggests that follicle suppression via rhAMH could be an effective pharmacological method for fertility preservation during chemotherapy.

Hadassa Roness
Hadassa Roness








Powered by Eventact EMS